SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Democratic gains in the midterms and the resulting political setback for Trump are the dominant focus, with traders linking the selloff in Trump Media to concerns about a weakened presidency, congressional gridlock, and potential investigations. The discussion is overwhelmingly bearish, though a few traders argue for buying the dip or a short squeeze.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros strong quarterly results and raised outlook have drawn attention, but traders are frustrated that the stock sold off despite the news. The debate centers on whether concerns about data-center regulation after the midterms, thin margins, customer concentration and cash conversion outweigh the AI-server growth story; some view the decline as an overreaction, while others question managements credibility and execution.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is caught in a sharp semiconductor selloff as traders fear that Democrats election gains could bring tighter data-center rules or slow AI infrastructure spending, weakening future memory demand. Bulls call the reaction an overblown market rotation and point to persistent AI-driven memory demand, while bears see risks to data-center investment and a cyclical memory downturn.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is under pressure amid election-related fears that tighter Texas and data-center rules could slow AI infrastructure expansion, alongside uncertainty ahead of earnings. Traders debate whether those risks outweigh the value of its existing power and data-center buildout, with some also pointing to a Microsoft contract as a potential cushion.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Fears that a Democratic win in Texas could slow or restrict data-center approvals have driven a sharp selloff in CIFR and other AI-infrastructure stocks. Bears warn that delays could threaten future growth, while bulls argue signed leases and projects already underway are less exposed and that AI demand remains intact.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples sharp rebound after its earnings-related selloff is driving attention, with traders describing a return to highs and debating whether a post-election rotation into mega-cap safe haven stocks and a short squeeze are behind the move. Bulls point to resilient demand and buying the dip, while skeptics question the rally given margin pressure from rising memory costs and Apples valuation.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is caught in a sharp memory-stock selloff as traders worry that election-related uncertainty could slow U.S. data-center expansion and weaken future AI memory demand, despite strong results and supply-shortage arguments. The community is split between viewing the decline as a buying opportunity ahead of the stock split and seeing it as a warning that the AI-memory trade has run too far or may face a cyclical downturn.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs strong quarterly results and upbeat data-center outlook have been overshadowed by a sharp reversal that erased much of its post-earnings gain. Traders debate whether election-related worries about data-center restrictions and AI spending, valuation concerns, or profit-taking drove the fade; bulls view the pullback as an overreaction to the companys growth outlook.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

UBER is drawing attention after Q3 results showed strong bookings growth and improving profitability, prompting a sharp rally. Traders are broadly bullish on the operating performance, while some question the softer Q4 outlook and weakness in Mobility revenue amid driver-supply concerns.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra is under heavy selling pressure after traders cited a KeyBanc downgrade tied to concerns that Texass Democratic election results could bring tighter data-center and energy-policy rules; the shares are also being discussed as part of a broader pullback in AI-power stocks. The community is split between viewing the move as an overreaction and buying opportunity, and worrying that political uncertainty could weigh on growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rapport Therapeutics (RAPP) Shares Sink 20% After Hours

Rapport Therapeutics stock falls after hours as investors assess proposed stock and convertible notes offerings.read more...

RAPP Stock Tempers Premarket Gains On Concerns Over Higher Discontinuation Rates In Bipolar Mania Study

Equity

The drug met its primary trial goal, producing a statistically significant 3.1-point improvement over placebo on a standard clinician-rated scale that measures the severity of manic symptoms.


Futures Slip As Korean Data Center IPO Faceplant Revives Tech Rout, French Spread Blows Out

Futures Slip As Korean Data Center IPO Faceplant Revives Tech Rout, French Spread Blows Out

 US futures are lower, led by the Nasdaq, as Monday's AI relief bounce fizzled overnight after South Korean data-center firm Elice cratered more than 30% in its trading debut, reviving doubts...

Rapport Therapeutics Scores Bipolar Mania Breakthrough as RAP-219 Advances Toward Phase 3

Rapport Therapeutics (NASDAQ:RAPP) delivered a major clinical milestone, announcing positive Phase 2 results for RAP-219 in adults experiencing acute bipolar mania. The randomized, double-blind, placebo-controlled trial enrolled 253 adults with bipolar I disorder and met both its primary and secondary endpoints, strengthening the case for a potential new treatment in a field where tolerability remains a significant challenge. With additional Phase 3 programs already underway in epilepsy, Rapport is building a broader development story around a single investigational drug with multiple potential applications.

The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte

Four biotech companies face key fall readouts that could influence the development and commercial prospects of their pipelines.

4 Biotech Stocks With Key Clinical Readouts Expected This Fall

KOD, CLDX, RAPP and PCVX face key clinical readouts this fall that could influence their drug and vaccine pipelines.

Rapport Therapeutics To Rally Around 76%? Here Are 10 Top Analyst Forecasts For Wednesday

Analysts raised targets for RAPP, ALLR, UNP and ALVO; cut targets for NU, CLLS and JBHT, with several rating upgrades and downgrades.read more...

What Does the Sale of Rapport Therapeutics Stock Worth Over $400,000 by the Chief Operating Officer Mean for Investors?

Key PointsCOO Cheryl Gault sold 10,000 shares on June 30, 2026, for a transaction value of ~$416,000, based on a weighted average price of $41.58 per share...

Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss

Rapport Therapeutics, Inc. (RAPP) delivered earnings and revenue surprises of +24.66% and 0.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Rapport Therapeutics (RAPP) Expected to Announce Quarterly Earnings on Thursday

Rapport Therapeutics (NASDAQ:RAPP) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Bearish Sentiment

<ul class="summary-bullets"><li>Citizens analyst Jason Butler lifted his price target on RAPP to $91 from $80 and kept an Outperform rating, saying the data reinforces RAP-219’s pipeline-in-a-product profile.</li><li>Wells Fargo acknowledged a positive efficacy signal but cautioned that upside may be limited by higher rates of agitation-related side effects and discontinuations.&nbsp;</li><li>Raymond James increased its target to $86 from $75 while keeping a Strong Buy, noting that the 3.1-point benefit fell short of the roughly 4-point threshold some investors had expected.</li></ul>Shares of Rapport Therapeutics (RAPP) rose 3% on Tuesday after the company reported positive mid-stage results for its experimental treatment in acute bipolar mania, including improvement in symptom severity, though concerns about safety tempered premarket gains. &nbsp;<h2 class="st-heading-2">RAPP Trial Clears Key Hurdles</h2>The study enrolled 253 adults with bipolar I disorder who were experiencing a manic episode. Participants received RAP-219 once daily or a placebo for three weeks. The drug met its primary goal, producing a statistically significant 3.1-point improvement over placebo on a standard clinician-rated scale that measures the severity of manic symptoms. A secondary measure of overall mania severity also improved significantly. Every individual symptom item on the scale showed a numerical benefit, the company said.Though there were no severe or serious adverse events in the trial, agitation was reported in 16.7% of patients on RAP-219 versus 9.4% on placebo. Discontinuations due to treatment-emergent adverse events were also higher at 3.2% versus 0.8%.RAP-219 is already in late-stage testing for epilepsy, and management has described the compound as a potential pipeline-in-a-product that could address multiple neurological and psychiatric conditions. The company plans to meet with the U.S. Food and Drug Administration in the first quarter of 2027 to discuss the bipolar findings and expects to start two late-stage trials in acute bipolar mania in the second half of 2027, the company said. Cash on hand is expected to fund operations into the second half of 2029.<h2 class="st-heading-2">Wall Street Weighs In</h2>Citizens analyst Jason Butler lifted his price target on RAPP to $91 from $80 and kept an Outperform rating, saying the data reinforces RAP-219’s pipeline-in-a-product profile and opens another multi-billion-dollar commercial opportunity. He raised his probability of approval to 50% from 35%.H.C. Wainwright, meanwhile, &nbsp;raised its target to $66 from $40 and maintained a Buy, citing consistent though modest improvements and suggesting that higher doses or longer treatment could strengthen efficacy across both psychiatric and epilepsy programs.Raymond James increased its target to $86 from $75 while keeping a Strong Buy, noting that the 3.1-point benefit fell short of the roughly 4-point threshold some investors had expected—an outcome that likely explained the stock’s pullback from premarket, where it rose as high as 84%. The firm raised its odds of success in bipolar to 55% from 33% and said the results would probably have been better received in a more constructive biotech market.Wells Fargo acknowledged a positive efficacy signal but cautioned that upside may be limited by higher rates of agitation-related side effects and discontinuations, maintaining an Overweight rating and a $51 target.<h2 class="st-heading-2">How Did RAPP Retail Traders React?</h2>On Stocktwits, retail sentiment around <a class="mention" data-mention="$RAPP" data-symbol-id="RAPP" href="https://stocktwits.com/symbol/RAPP" target="_blank">RAPP stock</a> jumped from neutral to extremely bullish territory over the past 24 hours, while message volume increased from high to extremely high levels.A Stocktwits user opined that RAPP is now a major buyout candidate and the only question is about price.<stembedurl>https://stocktwits.com/stockjock2424/message/666937700</stembedurl>Another user said that they are adding more shares of the company at current prices.<stembedurl>https://stocktwits.com/Donniechen12345/message/666935866</stembedurl>RAPP stock is down 3% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/lion-stock-rallies-as-dune-producer-reportedly-puts-offer-on-the-table-for-the-hunger-games-studio/cZxAcxRRBHe">LION Stock Rallies As Dune Producer Reportedly Puts Offer On The Table For The Hunger Games Studio</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Rapport Therapeutics is displayed on the screen of the smart tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

The drug met its primary trial goal, producing a statistically significant 3.1-point improvement over placebo on a standard clinician-rated scale that measures the severity of manic symptoms.

iShares Russell 2000 ETF

Rapport Therapeutics Inc

Vanguard Total Stock Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$25.79
Prev Close	$25.44
Open	$26.19
Dividend Yield	0.00%
50-Day Moving Average	$35.76
Beta	1.36
Avg. Volume	1.29M
PE Ratio	-8.36

52-Week High	$52.93
52-Week Low	$22.06
Market Capitalization	$1.22B
EPS (Annual)	-$2.86
Price to Book	2.88
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

RAPP Fundamentals